16 employees
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
2001
$3M
from 2 investors over 2 rounds
Benitec Biopharma raised $3M on August 11, 2023
Investors: Adage Capital Management and Suvretta Capital Management LLC